Growth Equity
Oxford Science Enterprises
Oxford Science Enterprises takes minority stakes in growing companies, usually without full control, from Oxford, United Kingdom. It states a focus on healthcare & life sciences, software & internet, materials & chemicals and industrials & manufacturing.
Stated investment criteria
What Oxford Science Enterprises says it buys
Read from Oxford Science Enterprises’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.
A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Oxford Science Enterprises to consider any particular business, and nothing on this page is represented as being for sale.
Regulatory record
How Oxford Science Enterprises is registered
From Companies House, the United Kingdom's statutory company register.
| Companies House number | 09093331 |
| Incorporated | 2014-06-19 |
| Register status | Active |
| Officers on the register | 12 |
Portfolio
Disclosed holdings
Companies Oxford Science Enterprises lists on its own website. No investment years are published.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| Acionna Therapeutics | — | — | — |
| Alethio (50+ companies) | — | — | — |
| Alethio Therapeutics | — | — | — |
| Allos | — | — | — |
| Alloyed | — | — | — |
| Alveogene | — | — | — |
| Amber Therapeutics | — | — | — |
| Archangel Lightworks | — | — | — |
| Ascension | — | — | — |
| Barinthus Biotherapeutics | — | — | — |
| Base Genomics | — | — | — |
| Beacon Therapeutics | — | — | — |
| BibliU | — | — | — |
| Caristo Diagnostics | — | — | — |
| Circadian Therapeutics | — | — | — |
| Credo Therapies | — | — | — |
| Dark Blue Therapeutics | — | — | — |
| DiffBlue | — | — | — |
| EndLyz Therapeutics | — | — | — |
| Evox Therapeutics | — | — | — |
| First Light Fusion | — | — | — |
| Fluorok | — | — | — |
| Fractile | — | — | — |
| Genomics | — | — | — |
| Grey Wolf Therapeutics | — | — | — |
| Ground Truth Labs | — | — | — |
| HEXR | — | — | — |
| ISOgenix | — | — | — |
| Iota Sciences | — | — | — |
| Kesmalea | — | — | — |
| Latent Logic | — | — | — |
| Marley Health | — | — | — |
| MatchBio | — | — | — |
| Mind Foundry | — | — | — |
| MiroBio | — | — | — |
| Mixergy | — | — | — |
| Moa Technology | — | — | — |
| Mode Labs | — | — | — |
| NavLive | — | — | — |
| Nucleome Therapeutics | — | — | — |
| OMass Therapeutics | — | — | — |
| ORFonyx | — | — | — |
| Opsydia | — | — | — |
| Orca Computing | — | — | — |
| Osler Diagnostics | — | — | — |
| Oxford Endovascular | — | — | — |
| Oxford Flow | — | — | — |
| Oxford Ionics | — | — | — |
| Oxford Nanoimaging | — | — | — |
| PQShield | — | — | — |
| PepGen | — | — | — |
| Perspectum | — | — | — |
| Prolific | — | — | — |
| Quantum Motion | — | — | — |
| Salience Labs | — | — | — |
| Scenic Biotech | — | — | — |
| Sitryx | — | — | — |
| Snowfox Discovery | — | — | — |
| T-Cypher Bio | — | — | — |
| Thelior Bio | — | — | — |
| Ultromics | — | — | — |
| Wild Bioscience | — | — | — |
| YASA | — | — | — |
Compiled from Oxford Science Enterprises’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Oxford Science Enterprises?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other growth equity investors active in healthcare & life sciences.